Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
9,742,725
-
Shares change
-
+307,850
-
Total reported value, excl. options
-
$62,159,250
-
Value change
-
+$1,863,710
-
Number of buys
-
20
-
Number of sells
-
-17
-
Price
-
$6.38
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2018
52 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2018.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,742,725 shares
of 27,691,200 outstanding shares and own 35.18% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (3,997,214 shares), venBio Select Advisor LLC (1,105,999 shares), 683 Capital Management, LLC (971,351 shares), Opaleye Management Inc. (900,000 shares), EVENTIDE ASSET MANAGEMENT, LLC (720,000 shares), BlackRock Inc. (562,216 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (364,933 shares), PUTNAM INVESTMENTS LLC (262,033 shares), STATE STREET CORP (161,918 shares), and UNITED SERVICES AUTOMOBILE ASSOCIATION (154,190 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.